E-Prescribing of Controlled Substances (EPCS)
Electronic Prescribing of Controlled Substances
DEA-regulated electronic prescribing of Schedule II-V controlled substances.
1 min read · Last reviewed May 23, 2026
At a glance
- Category
- Documentation
- Acronym for
- Electronic Prescribing of Controlled Substances
- Primary sources
- 2
- Workspace handoff
- compliance binder →
Where this comes up
Providers meet this term in the chart and at the post-visit review — encounter notes, problem lists, medication reconciliation, signed orders, and the time/elements that defend the billed code. If documentation does not support the code, the code does not survive an audit.
Full definition
What it is in practice
DEA EPCS requires identity proofing, two-factor authentication, and certified EHR/e-prescribing systems. CMS requires EPCS for Part D controlled-substance prescriptions.
How it shows up in your practice
Confirm the EHR's EPCS certification and the prescriber identity-proofing status. EPCS gaps can trigger Medicare Part D audits.
Sources
- DEA — Electronic Prescriptions for Controlled Substanceshttps://www.deadiversion.usdoj.gov/ecomm/e_rx/
- DEA — Controlled Substances Acthttps://www.deadiversion.usdoj.gov/21cfr/cfr/
Confirm EPCS configuration in the Compliance Binder
Open compliance binder →Related terms
- PayerMedicare Part DMedicare prescription drug coverage delivered through stand-alone PDPs or MA-PD plans.
- Compliance ProgramControlled Substances ActFederal statute (21 USC 801 et seq.) regulating the manufacture, distribution, and dispensing of controlled substances.
- SecurityMFA (Multi-Factor Authentication)Authentication requiring two or more independent factors — something you know, have, or are.
D3rx is a healthcare-billing and compliance research aid maintained by D3rx Inc. Articles are drafted by an LLM (Anthropic Claude) against primary HHS, OCR, CMS, eCFR, NIST, and state-regulator publications, and reviewed for restraint and source fidelity by the D3rx team.
Reviewer status: a named credentialed reviewer (CHC, CHPC, or healthcare attorney) is being engaged. Until that engagement is finalized, this page does not claim credentialed review.
Related across the archive
- GlossaryControlled Substances ActFederal statute (21 USC 801 et seq.) regulating the manufacture, distribution, and dispensing of controlled substances.
- GlossaryMedicare Part DMedicare prescription drug coverage delivered through stand-alone PDPs or MA-PD plans.
- GlossaryMFA (Multi-Factor Authentication)Authentication requiring two or more independent factors — something you know, have, or are.
- GlossaryPrescription Drug Monitoring Program (PDMP)State-administered electronic database tracking controlled substance prescriptions.
- GlossaryAddendum to Medical RecordA signed and dated note added to a medical record after the original encounter to clarify or supplement documentation.
- GlossaryDesignated Health Service (DHS)Categories of services subject to the physician self-referral prohibition under the Stark Law.
- GlossaryDocumentation CloningThe practice of copying prior or template-generated documentation into a new encounter note without updating it for the current visit.
- GlossaryDocumentation SpecificityThe level of detail in clinical documentation needed to support the diagnosis and service codes reported.
This glossary entry is a research aid for billing and compliance staff. It does not provide legal, medical, or financial advice and does not replace counsel. References cited link to primary sources at HHS, OCR, CMS, eCFR, NIST, and the relevant payer or industry body.